Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kiragu

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Opinion in HIV and AIDS|November 18, 2015
The preexposure prophylaxis revolution; from clinical trials to programmatic implementationNelly R Mugo, Kenneth Ngure, Michael Kiragu, et al.
BMJ Open|June 14, 2022
On the road to universal coverage of postnatal care: considerations for a targeted postnatal care approach for at-risk mother-baby dyads in low-income and middle-income countries informed by a consultation with global expertsAngela Muriuki, Melanie Yahner, Michael Kiragu, et al.
AIDS and Behavior|July 23, 2020
Does Capacity Development Increase Demand for Health Services and Rights Among Key Populations Affected by HIV? A Systematic Review of Evidence from Low and Middle-Income CountriesMichael Kiragu, Virginia A Fonner, Samuel Munyuwiny, et al.
Plos One|November 20, 2023
Proximate and distant determinants of maternal and neonatal mortality in the postnatal period: A scoping review of data from low- and middle-income countriesPreston Izulla, Angela Muriuki, Michael Kiragu, et al.
Plos One|April 14, 2016
"How I Wish This Thing Was Initiated 100 Years Ago!" Willingness to Take Daily Oral Pre-Exposure Prophylaxis among Men Who Have Sex with Men in KenyaRobinson Njoroge Karuga, Serah Nduta Njenga, Rueben Mulwa, et al.
The Lancet. HIV|February 25, 2017
PrEP for key populations in combination HIV prevention in Nairobi: a mathematical modelling studyIde Cremin, Lyle McKinnon, Joshua Kimani, et al.
JAMA|March 1, 2024
HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender WomenJeanne Marrazzo, Li Tao, Marissa Becker, et al.
Sexual Health|November 9, 2018
Pre-exposure prophylaxis rollout in a national public sector program: the Kenyan case studySarah Masyuko, Irene Mukui, Olivia Njathi, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Opinion in HIV and AIDS|November 18, 2015
The preexposure prophylaxis revolution; from clinical trials to programmatic implementationNelly R Mugo, Kenneth Ngure, Michael Kiragu, et al.
BMJ Open|June 14, 2022
On the road to universal coverage of postnatal care: considerations for a targeted postnatal care approach for at-risk mother-baby dyads in low-income and middle-income countries informed by a consultation with global expertsAngela Muriuki, Melanie Yahner, Michael Kiragu, et al.
AIDS and Behavior|July 23, 2020
Does Capacity Development Increase Demand for Health Services and Rights Among Key Populations Affected by HIV? A Systematic Review of Evidence from Low and Middle-Income CountriesMichael Kiragu, Virginia A Fonner, Samuel Munyuwiny, et al.
Plos One|November 20, 2023
Proximate and distant determinants of maternal and neonatal mortality in the postnatal period: A scoping review of data from low- and middle-income countriesPreston Izulla, Angela Muriuki, Michael Kiragu, et al.
Plos One|April 14, 2016
"How I Wish This Thing Was Initiated 100 Years Ago!" Willingness to Take Daily Oral Pre-Exposure Prophylaxis among Men Who Have Sex with Men in KenyaRobinson Njoroge Karuga, Serah Nduta Njenga, Rueben Mulwa, et al.
The Lancet. HIV|February 25, 2017
PrEP for key populations in combination HIV prevention in Nairobi: a mathematical modelling studyIde Cremin, Lyle McKinnon, Joshua Kimani, et al.
JAMA|March 1, 2024
HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender WomenJeanne Marrazzo, Li Tao, Marissa Becker, et al.
Sexual Health|November 9, 2018
Pre-exposure prophylaxis rollout in a national public sector program: the Kenyan case studySarah Masyuko, Irene Mukui, Olivia Njathi, et al.
Pageof 1